Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CHESON, Bruce D")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 68

  • Page / 3
Export

Selection :

  • and

Staging and Evaluation of the Patient with LymphomaCHESON, Bruce D.Hematology/oncology clinics of North America. 2008, Vol 22, Num 5, issn 0889-8588, vii-viii, 825-837 [15 p.]Article

Monoclonal antibody therapy for B-cell malignanciesCHESON, Bruce D.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, S2-S14, SUP5Article

Non-Hodgkin's Lymphomas: New Insights and Therapeutic StrategiesCHESON, Bruce D.Hematology/oncology clinics of North America. 2008, Vol 22, Num 5, issn 0889-8588, 314 p.Serial Issue

Chronic Lymphocytic Leukemia in the Purine Analog Era: New Insights and Challenges. SymposiumCHESON, Bruce D.Seminars in hematology. 1998, Vol 35, Num 3, issn 0037-1963, 36 p., SUP3Conference Proceedings

Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell MalignanciesCHESON, Bruce D.Journal of clinical oncology. 2010, Vol 28, Num 21, pp 3525-3530, issn 0732-183X, 6 p.Article

Novel therapies for peripheral T-cell non-Hodgkin's lymphomasCHESON, Bruce D.Current opinion in hematology. 2009, Vol 16, Num 4, pp 299-305, issn 1065-6251, 7 p.Article

Monoclonal antibody therapy of chronic lymphocytic leukemia : Immunotherapy in Chronic Lymphocytic LeukemiaCHESON, Bruce D.Cancer immunology and immunotherapy. 2006, Vol 55, Num 2, pp 188-196, issn 0340-7004, 9 p.Article

The role of alemtuzumab (Campath) in the treatment of hematologic malignanciesCHESON, Bruce D.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, 54 p., SUP5Serial Issue

Future Strategies Toward the Cure of Indolent B-Cell MalignanciesCHESON, Bruce D.Seminars in hematology. 1999, Vol 36, Num 4, issn 0037-1963, SUP5Serial Issue

The Optimal Management of Follicular Lymphoma: An Evolving FieldUJJANI, Chaitra; CHESON, Bruce D.Drugs (Basel). 2013, Vol 73, Num 13, pp 1395-1403, issn 0012-6667, 9 p.Article

The role of alemtuzumab in the management of T-cell malignanciesDEARDEN, Claire.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, S44-S52, SUP5Article

The role of alemtuzumab in nonmyeloablative hematopoietic transplantationGIRALT, Sergio.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, S36-S43, SUP5Article

Novel therapeutic strategies with alemtuzumab for chronic lymphocytic leukemiaRAI, Kanti R.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, S15-S22, SUP5Article

Pre- and post-treatment evaluation of non-Hodgkin's lymphomaMAVROMATIS, Blanche H; CHESON, Bruce D.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 3, pp 429-447, issn 1521-6926, 19 p.Article

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's LymphomaCHESON, Bruce D; LEONARD, John P.The New England journal of medicine. 2008, Vol 359, Num 6, pp 613-626, issn 0028-4793, 14 p.Article

HighlyAggressive Lymphomas in AdultsSWEETENHAM, John W.Hematology/oncology clinics of North America. 2008, Vol 22, Num 5, issn 0889-8588, ix, 965-978 [15 p.]Article

Stem Cell Transplantation for Non-Hodgkin's LymphomaWRENCH, David; GRIBBEN, John G.Hematology/oncology clinics of North America. 2008, Vol 22, Num 5, issn 0889-8588, xi, 1051-1079 [30 p.]Article

Therapy for previously untreated chronic lymphocytic leukemia : A reevaluationCHESON, B. D.Seminars in hematology. 1998, Vol 35, Num 3, pp 14-21, issn 0037-1963, SUP3Conference Paper

Bendamustine : Rebirth of an Old DrugCHESON, Bruce D; RUMMEL, Mathias J.Journal of clinical oncology. 2009, Vol 27, Num 9, pp 1492-1501, issn 0732-183X, 10 p.Article

Lenalidomide for the Treatment of B-Cell MalignanciesCHANAN-KHAN, Ashera; CHESON, Bruce D.Journal of clinical oncology. 2008, Vol 26, Num 9, pp 1544-1552, issn 0732-183X, 9 p.Article

Follicular Lymphoma : Clinical Features and TreatmentTAN, Daryl; HORNING, Sandra J.Hematology/oncology clinics of North America. 2008, Vol 22, Num 5, issn 0889-8588, viii, 863-882 [21 p.]Article

Clinical Management of T-Cell Malignancies : Current Perspectives, Key Issues, and Emerging TherapiesCHESON, Bruce D.Seminars in oncology. 2007, Vol 34, Num 6, issn 0093-7754, S3-S7, SUP5Article

Novel therapies for chronic lymphocytic leukemiaMAVROMATIS, Blanche H; CHESON, Bruce D.Blood reviews. 2004, Vol 18, Num 2, pp 137-148, issn 0268-960X, 12 p.Article

Molecular genetic approachesKIPPS, T. J.Seminars in hematology. 1999, Vol 36, Num 4, pp 3-8, issn 0037-1963, SUP5Article

Immune recognition and antiselfNADLER, L. M.Seminars in hematology. 1999, Vol 36, Num 4, pp 9-11, issn 0037-1963, SUP5Article

  • Page / 3